PAXORLEA Trademark

Trademark Overview

On Wednesday, May 1, 2019, a trademark application was filed for PAXORLEA with the United States Patent and Trademark Office. The USPTO has given the PAXORLEA trademark a serial number of 88410920. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 1, 2023. This trademark is owned by Athenex, Inc.. The PAXORLEA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and drugs for use in the treatment of cancer; Pharmaceutical preparations and drugs for use in chemotherapy; Pharmaceutical preparations and drugs for use in the field of oncology and immuno-oncology; Pharmaceutical preparations and drugs for use in the treatment of oncological diseases and disorders; Tumor suppressing pharmaceutical preparations and drugs; Pharmaceutical products for the prevention and treatment of cancer; Chemotherapeutic drugs
paxorlea

General Information

Serial Number88410920
Word MarkPAXORLEA
Filing DateWednesday, May 1, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 1, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and drugs for use in the treatment of cancer; Pharmaceutical preparations and drugs for use in chemotherapy; Pharmaceutical preparations and drugs for use in the field of oncology and immuno-oncology; Pharmaceutical preparations and drugs for use in the treatment of oncological diseases and disorders; Tumor suppressing pharmaceutical preparations and drugs; Pharmaceutical products for the prevention and treatment of cancer; Chemotherapeutic drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 17, 2019
Primary Code005
First Use Anywhere DateFriday, September 30, 2022
First Use In Commerce DateFriday, September 30, 2022

Trademark Owner History

Party NameAthenex, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBuffalo, NY 14203
Party NameAthenex, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBuffalo, NY 14203

Trademark Events

Event DateEvent Description
Monday, May 1, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 1, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, May 1, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, January 4, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, January 4, 2023FINAL REFUSAL E-MAILED
Wednesday, January 4, 2023SU - FINAL REFUSAL - WRITTEN
Thursday, December 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 8, 2022ASSIGNED TO LIE
Wednesday, November 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 7, 2022NON-FINAL ACTION E-MAILED
Monday, November 7, 2022SU - NON-FINAL ACTION - WRITTEN
Saturday, October 29, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 26, 2022USE AMENDMENT FILED
Wednesday, October 26, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, May 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 10, 2022SOU EXTENSION 5 GRANTED
Tuesday, May 3, 2022SOU EXTENSION 5 FILED
Tuesday, May 10, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 3, 2022SOU TEAS EXTENSION RECEIVED
Saturday, November 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 11, 2021SOU EXTENSION 4 GRANTED
Thursday, November 11, 2021SOU EXTENSION 4 FILED
Thursday, November 11, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 28, 2021SOU EXTENSION 3 GRANTED
Friday, May 28, 2021SOU EXTENSION 3 FILED
Friday, May 28, 2021SOU TEAS EXTENSION RECEIVED
Thursday, November 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 24, 2020SOU EXTENSION 2 GRANTED
Tuesday, November 24, 2020SOU EXTENSION 2 FILED
Tuesday, November 24, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 24, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 24, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 24, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 24, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 22, 2020SOU EXTENSION 1 GRANTED
Friday, May 22, 2020SOU EXTENSION 1 FILED
Friday, May 22, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, December 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 5, 2019ASSIGNED TO LIE
Tuesday, September 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 23, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, July 23, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 23, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, July 23, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, July 15, 2019ASSIGNED TO EXAMINER
Friday, May 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 4, 2019NEW APPLICATION ENTERED

Related Keywords

paxorlea pharmaceutical drugs preparations treatment cancer oncology suppressing products chemotherapeutic tumor